US Patent Issued to UNIVERSITAT LINZ on March 3 for "Use of leoligin in the prevention of tissue damage" (Austrian Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,570, issued on March 3, was assigned to UNIVERSITAT LINZ (Linz, Austria).

"Use of leoligin in the prevention of tissue damage" was invented by David Bernhard (Linz, Austria) and Marina Muller (Gallneukirchen, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides for leoligin or a derivative thereof for use in the prevention and/or reduction of tissue damages, wherein leoligin or the derivative thereof is administered systemically to the subject in need thereof."

The patent was filed on Aug. 27, 2021, under Application No. 18/024,039.

*For further information, including images, charts and tables, please visit: http:/...